Linear mRNA and Circular RNA Technology
- Efficient, stable, and novel antigen and sequence element designs offer differentiated advantages for products.
- Numerous innovative patented technologies, including Poly A tail and circular RNA technologies.
Efficient Targeted Delivery
- Proprietary high-efficiency and safe mRNA vaccine delivery carriers have been utilized in pipeline development and have received IND approval.
- A library of over 10,000 ionizable cationic lipids, with several exceptional lipid molecules demonstrating extrahepatic expression suitable for various clinical applications.
- Targeted delivery and selective expression based on biological mechanisms aim to overcome the bottleneck of LNP delivery.
Robust CMC Production
- Comprehensive platforms for RNA drug and vaccine production, purification, and formulation processes.
- Established quality control and testing systems, with products validated by the National Institute for Food and Drug Control.
- Scalable processes to meet commercialization needs.
Data Science and AI
- Antigen and sequence design.
- Ionizable lipid and targeted delivery design.
- Process design and optimization.
- Multiple software copyrights.